APA

Sandmaier B. M., Kornblit B., Storer B. E., Olesen G., Maris M. B., Langston A. A., Gutman J. A., Petersen S. L., Chauncey T. R., Bethge W. A., Pulsipher M. A., Woolfrey A. E., Mielcarek M., Martin P. J., Appelbaum F. R., Flowers M. E. D., Maloney D. G. & Storb R. (20191030). Addition of sirolimus to standard cyclosporine plus mycophenolate mofetil-based graft-versus-host disease prophylaxis for patients after unrelated non-myeloablative haemopoietic stem cell transplantation: a multicentre, randomised, phase 3 trial. : The Lancet. Haematology.

Chicago

Sandmaier Brenda M, Kornblit Brian, Storer Barry E, Olesen Gitte, Maris Michael B, Langston Amelia A, Gutman Jonathan A, Petersen Soeren L, Chauncey Thomas R, Bethge Wolfgang A, Pulsipher Michael A, Woolfrey Ann E, Mielcarek Marco, Martin Paul J, Appelbaum Fred R, Flowers Mary E D, Maloney David G and Storb Rainer. 20191030. Addition of sirolimus to standard cyclosporine plus mycophenolate mofetil-based graft-versus-host disease prophylaxis for patients after unrelated non-myeloablative haemopoietic stem cell transplantation: a multicentre, randomised, phase 3 trial. : The Lancet. Haematology.

Harvard

Sandmaier B. M., Kornblit B., Storer B. E., Olesen G., Maris M. B., Langston A. A., Gutman J. A., Petersen S. L., Chauncey T. R., Bethge W. A., Pulsipher M. A., Woolfrey A. E., Mielcarek M., Martin P. J., Appelbaum F. R., Flowers M. E. D., Maloney D. G. and Storb R. (20191030). Addition of sirolimus to standard cyclosporine plus mycophenolate mofetil-based graft-versus-host disease prophylaxis for patients after unrelated non-myeloablative haemopoietic stem cell transplantation: a multicentre, randomised, phase 3 trial. : The Lancet. Haematology.

MLA

Sandmaier Brenda M, Kornblit Brian, Storer Barry E, Olesen Gitte, Maris Michael B, Langston Amelia A, Gutman Jonathan A, Petersen Soeren L, Chauncey Thomas R, Bethge Wolfgang A, Pulsipher Michael A, Woolfrey Ann E, Mielcarek Marco, Martin Paul J, Appelbaum Fred R, Flowers Mary E D, Maloney David G and Storb Rainer. Addition of sirolimus to standard cyclosporine plus mycophenolate mofetil-based graft-versus-host disease prophylaxis for patients after unrelated non-myeloablative haemopoietic stem cell transplantation: a multicentre, randomised, phase 3 trial. : The Lancet. Haematology. 20191030.